28. 全身性アミロイドーシス Systemic amyloidosis Clinical trials / Disease details

臨床試験数 : 267 / 薬物数 : 241 - (DrugBank : 77) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 180

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00052884 (ClinicalTrials.gov)	October 2003	24/1/2003	Amifostineand Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Pe ...	A Phase I Study of AmifostineFollowed by High-Dose Escalation of Melphalan With Stem Cell Reconstitu ...	Drug/Agent Toxicity by Tissue/Organ;Multiple Myeloma and Plasma Cell Neoplasm	Biological: filgrastim;Drug: amifostine trihydrate;Drug: melphalan;Procedure: bone marrow ablation wi ...	Eastern Cooperative Oncology Group	National Cancer Institute (NCI)	Terminated	18 Years	70 Years	Both	8	Phase 1	United States

First Previous1Next Last